Shopping Cart
- Remove All
Your shopping cart is currently empty
MK-3328 has a high affinity for β-Amyloid (IC50:10.5 nM), and can be used as a candidate PET ligand for clinical assessment of β-amyloid plaque load. MK-3328 is a potential treatment for Alzheimer's disease.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $350 | In Stock | |
| 5 mg | $828 | In Stock | |
| 10 mg | $1,130 | In Stock | |
| 25 mg | $1,590 | In Stock | |
| 50 mg | $1,980 | In Stock | |
| 100 mg | $2,500 | In Stock | |
| 500 mg | $4,900 | In Stock |
| Description | MK-3328 has a high affinity for β-Amyloid (IC50:10.5 nM), and can be used as a candidate PET ligand for clinical assessment of β-amyloid plaque load. MK-3328 is a potential treatment for Alzheimer's disease. |
| Targets&IC50 | β-Amyloid:10.5 nM |
| In vitro | MK-3328 displays amyloid binding potency balanced with low levels of nonspecific binding.[1] |
| In vivo | In normal rhesus monkey positron emission tomography (PET) imaging studies, [18F]MK-3328 demonstrates favorable kinetics, exhibiting high brain uptake, and good washout.[2] |
| Molecular Weight | 268.25 |
| Formula | C14H9FN4O |
| Cas No. | 1201323-97-8 |
| Smiles | FC=1N=C2OC(=NC2=CC1)C=3C=C4C(=NC3)N(C)C=C4 |
| Relative Density. | 1.51 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: Slightly soluble |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.